Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 19 December 2008:
Vol. 322. no. 5909, pp. 1861 - 1865
DOI: 10.1126/science.1164390

Reports

Leukemic Cells Create Bone Marrow Niches That Disrupt the Behavior of Normal Hematopoietic Progenitor Cells

Angela Colmone, Maria Amorim, Andrea L. Pontier, Sheng Wang, Elizabeth Jablonski, Dorothy A. Sipkins*

The host tissue microenvironment influences malignant cell proliferation and metastasis, but little is known about how tumor-induced changes in the microenvironment affect benign cellular ecosystems. Applying dynamic in vivo imaging to a mouse model, we show that leukemic cell growth disrupts normal hematopoietic progenitor cell (HPC) bone marrow niches and creates abnormal microenvironments that sequester transplanted human CD34+ (HPC-enriched) cells. CD34+ cells in leukemic mice declined in number over time and failed to mobilize into the peripheral circulation in response to cytokine stimulation. Neutralization of stem cell factor (SCF) secreted by leukemic cells inhibited CD34+ cell migration into malignant niches, normalized CD34+ cell numbers, and restored CD34+ cell mobilization in leukemic mice. These data suggest that the tumor microenvironment causes HPC dysfunction by usurping normal HPC niches and that therapeutic inhibition of HPC interaction with tumor niches may help maintain normal progenitor cell function in the setting of malignancy.

Department of Medicine, Section of Hematology/Oncology, The University of Chicago, 5841 South Maryland Avenue MC 2115, Chicago, IL 60637, USA.

* To whom correspondence should be addressed: E-mail: dsipkins{at}medicine.bsd.uchicago.edu

Read the Full Text



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Kinetics of normal hematopoietic stem and progenitor cells in a Notch1-induced leukemia model.
X. Hu, H. Shen, C. Tian, H. Yu, G. Zheng, R. XuFeng, Z. Ju, J. Xu, J. Wang, and T. Cheng (2009)
Blood 114, 3783-3792
   Abstract »    Full Text »    PDF »
The microenvironment in mature B-cell malignancies: a target for new treatment strategies.
J. A. Burger, P. Ghia, A. Rosenwald, and F. Caligaris-Cappio (2009)
Blood 114, 3367-3375
   Abstract »    Full Text »    PDF »
Inhibition of the SDF-1{alpha}-CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I Tax transgenic mice.
A. Kawaguchi, Y. Orba, T. Kimura, H. Iha, M. Ogata, T. Tsuji, A. Ainai, T. Sata, T. Okamoto, W. W. Hall, et al. (2009)
Blood 114, 2961-2968
   Abstract »    Full Text »    PDF »
The leukemic stem cell niche: current concepts and therapeutic opportunities.
S. W. Lane, D. T. Scadden, and D. G. Gilliland (2009)
Blood 114, 1150-1157
   Abstract »    Full Text »    PDF »
Altered cellular dynamics and endosteal location of aged early hematopoietic progenitor cells revealed by time-lapse intravital imaging in long bones.
A. Kohler, V. Schmithorst, M.-D. Filippi, M. A. Ryan, D. Daria, M. Gunzer, and H. Geiger (2009)
Blood 114, 290-298
   Abstract »    Full Text »    PDF »
This extraordinary extramedullary haematopoiesis.
M. S. Goligorsky (2009)
Nephrol. Dial. Transplant. 24, 2016-2017
   Full Text »    PDF »
Another nail in the AML coffin.
C. N. Abboud (2009)
Blood 113, 6045-6046
   Full Text »    PDF »
Optimal Mobilization of Normal and Leukemic Stem Cells via Modulation of Chemokine and Integrin Axes.
M. A. Schroeder, M. P. Rettig, P. Ramirez, and J. F. DiPersio (2009)
Am. Assoc. Cancer Res. Educ. Book 2009, 15-22
   Full Text »    PDF »
Darwin and evolutionary tales in leukemia.
M. Greaves (2009)
Hematology 2009, 3-12
   Abstract »    Full Text »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)